180 Life Sciences Corp (ATNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Operating Expenses | 4,462 | 4,218 | 4,013 | 2,948 | 2,416 |
Operating Income | -4,462 | -4,218 | -4,013 | -2,948 | -2,416 |
Interest Expense | 13 | 20 | 26 | 127 | 614 |
Other Income | 5,505 | 22,528 | -19,425 | -13,129 | -4,916 |
Pre-tax Income | 1,030 | 18,291 | -23,465 | -16,204 | -7,946 |
Income Tax | -40 | 6 | 6 | 5 | -25 |
Net Income Continuous | 1,069 | 18,286 | -23,470 | -16,209 | -7,921 |
Net Income | $1,036 | $18,297 | $-23,459 | $-16,199 | $-7,931 |
EPS Basic Total Ops | 46.39 | 212.93 | -285.17 | -220.53 | -186.31 |
EPS Basic Continuous Ops | 45.29 | 212.44 | -283.67 | -220.49 | -161.06 |
EPS Diluted Total Ops | 171.86 | 87.45 | -285.17 | -220.53 | -186.31 |
EPS Diluted Continuous Ops | 51.48 | 206.25 | -283.67 | -220.49 | -160.89 |
EBITDA(a) | $-3,464 | $-3,748 | $-3,640 | $-1,827 | $-910 |